<DOC>
	<DOCNO>NCT00150384</DOCNO>
	<brief_summary>The purpose demonstrate utility Caduet ( amlodipine/atorvastatin ) African American population</brief_summary>
	<brief_title>Clinical Utility Caduet Achieving Blood Pressure Lipid Endpoints Specific Patient Population</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Amlodipine , atorvastatin drug combination</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>African American men woman concurrent hypertension dyslipidemia either treat untreated Subjects must satisfy blood pressure LDLC inclusion criterion respective Cardiovascular Risk group determine screen Subjects currently treat concomitant amlodipine atorvastatin therapy , include Caduet Subjects blood pressure goal</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>